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NC-ND license (http://creativecommoAbstract In a case of unexplained digestive hemorrhage after normal gastroscopy and colo-
noscopy, it is necessary to consider hemorrhagic tumors of the small intestine, particularly
stromal tumors. We describe the case of a 73-year-old woman who presented with symptoms
of massive hematochezia and abdominal pain. Abdominal examination revealed: distension,
board-like rigidity, and muscular defense in the right upper quadrant; no liver dullness; and
inaudible bowel sounds. In addition, rectal examination revealed an empty ampulla. Colono-
scopic and gastroscopic evaluations were normal and did not reveal the origin of the bleeding.
An abdominal enhanced computed tomography scan revealed a 9.2 cm  10 cm solid tumor
with a low-density area, suggesting necrosis or abscess. After the overall examination, a
gastrointestinal stromal tumor (GIST) of the jejunum was highly suspected. Intraoperative find-
ings showed an excessive bloody fluid collection, approximately 1600 mL in the abdominal cav-
ity. Furthermore, an outgrown mass ruptured in the jejunum,w5 cm from the Treitz ligament.
We deemed the tumor to be a moderately differentiated GIST originating from the jejunum. In
this report, we review the literature on this rare condition and discuss potential strategies for
diagnosing and managing patients with a spontaneous rupture of an extremely large GIST of the
jejunum.
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Rupture of a giant gastrointestinal stromal tumor 1971. Introduction
Gastrointestinal stromal tumors (GISTs) are rare and spe-
cific tumors of the gastrointestinal system that originate
from Cajal cells located at different sites of the digestive
tract. Such tumors may originate from the omentum and
peritoneum but are commonly located in the stomach and
small bowel. The annual incidence of GIST is one in 10e20
million persons, with a malignant potential of 20e30%.1
Gastrointestinal bleeding is the most common presenta-
tion (50%) of GISTs and is typically associated with an ul-
ceration of the tumor into the lumen.2 Severe symptoms,
such as profuse lower gastrointestinal bleeding or acute
abdominal pain, are unusual. Small lesions are typically
asymptomatic. Spontaneous rupture of GISTs of the
jejunum with massive lower gastrointestinal bleeding is
rare. Most GISTs measure > 5 cm in diameter at diagnosis,
with a diameter of 10 cm being associated with a higher risk
of local or distant metastasis.3 We present the case of
spontaneous rupture of a large GIST of the jejunum.
2. Case Report
A 73-year-old woman presented with symptoms of massive
hematochezia and abdominal pain. Her blood pressure was
116/58 mmHg, pulse rate 78 beats/min, and temperature
36.4C. Abdominal examination revealed: distension,
board-like rigidity, and muscular defense in the right upper
quadrant; no liver dullness; inaudible bowel sounds; and a
palpable mass over the right upper quadrant. Moreover,
rectal examination revealed an empty ampulla. Blood tests
showed a hemoglobin level of 8.2 g/dL, white blood cell
count of 14.57  109/L, and C-reactive protein of 0.1 mg/
dL. Colonoscopic and gastroscopic evaluations were normal
and did not reveal the origin of the bleeding. An abdominal
enhanced computed tomography (CT) scan revealed a
9.2 cm  10 cm solid tumor with a low density area, sug-
gesting necrosis or abscess (Figure 1). A radiological diag-
nosis suspected a carcinoid or GIST arising from the
jejunum. No free fluid was identified around the mass in the
abdominal cavity.Figure 1 Abdominal enhanced computed tomography scan,
revealing a 9.2 cm  10 cm solid tumor with a low-density area,
suggesting necrosis or abscess.During hospitalization, the patient was treated with
intravenous administration and blood transfusion. The pa-
tient subsequently registered improvement in her clinical
condition and laboratory tests. However, sudden diffuse
abdominal pain with peritonitis was noted 4 days later; we
suspected that the peritonitis was induced by mass rupture
and we thus performed emergency laparotomy under gen-
eral anesthesia. Intraoperative findings showed an exces-
sive bloody fluid collection, w1600 mL in the peritoneal
cavity. An outgrown mass ruptured in the jejunum, w5 cm
from the Treitz ligament without seeding to nearby soft
tissues (Figure 2). We performed segmental resection of the
jejunum with the tumor and end-to-end anastomosis. The
resected mass was a well-circumscribed tumor measuring
approximately 10 cm  8 cm (Figure 3). Hematoxylineeosin
staining showed an intramuscular tumor (Figure 4), with
focal hemorrhage and necrosis (Figure 5), composed of
spindle-shaped and epithelioid cell proliferation (Figure 6).
The mitosis index was 6 in 50 higher power fields and of a
high grade (over 50 high-power fields). Immunohistochem-
ical staining showed positive results for c-kit and DOG1
(Figure 7). The largest dimension of the tumor was 9.5 cm
(pT3), and cellular atypia was moderated. We deemed the
tumor to be a moderately differentiated GIST originating
from the jejunum. The pathological tumorenodeemeta-
stasis stage of spontaneous rupture of the GIST of the
jejunum was IIIB. The patient expired because of intestinal
obstruction with community-associated pneumonia and
septic shock in the postoperative period.3. Discussion
The annual incidence of GIST is one in 10e20 million per-
sons, with a malignant potential of 20e30%.1 GISTs have a
wide range of malignancy rates, and it is preferable to
consider and treat them as potentially malignant.4
Approximately 60e70% of cases occur in the stomach,
25e35% in the small intestine, and 10% in the jejunum,
whereas the esophagus, colon, rectum, and appendix are
rarely affected.4Figure 2 Ruptured tumor in expenses of the proximal
jejunum.
Figure 3 Segmental resection of the jejunal tumor.
Figure 4 The tumor extends through the muscularis propria
and subserosa and penetrates the serosa (40 magnification).
Figure 5 (A) Histologically, the extremely large jejunal
tumor composed of hemorrhage and necrosis. (B) Distinctive
extracellular collagen globules and more cellular components
containing uniform spindle cells (400 magnification).
Figure 6 Epithelioid composed of spindle-shaped cells and
epithelioid cell proliferation (400 magnification).
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vere, and complications include vague abdominal pain,
hematemesis, and intestinal obstruction. Common pre-
sentations include abdominal pain, palpable mass, gastro-
intestinal bleeding, fever, anorexia, weight loss, and
anemia.5 The symptoms and signs are not disease-specific;
therefore, w50% of GISTs have already metastasized at
diagnosis, typically to the liver or peritoneum.4
Over the past decade, several studies have reported
spontaneous perforation of jejunal GISTs.2,6
An isolated jejunal GIST associated with perforation and
peritonitis is rare.1 GISTs originating in the jejunum seldom
cause perforation and acute diffuse peritonitis.2
Most GISTs are > 5 cm in diameter at diagnosis; a
diameter of 10 cm is associated with a higher risk of local or
distant metastasis.3
The gastrointestinal lumen is the most common site of
spontaneous rupture of GISTs. The primary symptom in our
patient was abdominal pain with lower gastrointestinal
bleeding due to a spontaneous rupture of a giant GIST of the
jejunum, which is highly atypical.
Considering the exophytic growth of tumors, intestinal
obstruction occurs because of compression rather thanluminal obstruction.5 Pressure necrosis and an ulceration of
the overlying mucosa may cause gastrointestinal bleeding,
and patients with considerable blood loss may experience
malaise and fatigue. Gastrointestinal bleeding is the most
common presentation (50%) of GISTs and is typically
Figure 7 Immunohistochemical staining revealed positive
findings for (A) CD117 and (B) DOG1.
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Perforation is generally attributed to: the replacement of
the bowel wall by tumor cells; tumor embolization, leading
to ischemia; and necrosis in addition to increased intra-
luminal pressure.5
Preoperative imaging modalities, such as contrast-
enhanced abdominal CT, facilitate diagnosis.8 Helical CT
plays a crucial role in the diagnosis of intraluminal or exo-
phytic tumors. The differential diagnosis of GI tract tumors
should include fibromatosis, leiomyoma, schwannoma, in-
flammatory fibroid polyp, and leiomyosarcoma.3 CT is the
most frequently performed imaging modality to locate the
site of origin of tumors; the extent of the tumor, metas-
tases, and involvement of other organs can also be
assessed. Dedicated magnetic resonance imaging provides
more detailed information than does CT in a preoperative
staging workup.8
Although extraluminal in origin, GISTs may ulcerate
through the overlying mucosa, causing intraluminal
bleeding.3 The stromal collagen is minimal in most GISTs;
however, delicate, thin-walled vessels may be prominent,
rendering stromal hemorrhage a common feature of these
tumors.7 Bleeding into the peritoneal cavity because of a
ruptured GIST can engender acute abdominal pain, pre-
senting a surgical emergency.2 The mechanism underlying
hemoperitoneum may be related to bleeding in the tumor,
leading to hematoma and rupture of the capsule ortransudation of blood components from the tumor.3 In
addition to the tumor size, mitotic rate, and tumor loca-
tion, tumor rupture is considered a prognostic factor for
outcomes in patients with GISTs.7 Metastatic seeding typi-
cally occurs in the peritoneal cavity and liver, followed by
the lungs and bones.3
Preoperative percutaneous fine-needle aspiration of tu-
mors for diagnostic purposes is not indicated because of the
risk of potential intraperitoneal migration or tumor
rupture.4 For GISTs, prognostic markers, namely tumor size
> 5 cm, mitotic rate > 5/50 high-power fields, tumor ne-
crosis, and Ki-67 (MIB-1) index > 10%, are all associated
with tumor malignancy and high mortality. The main prog-
nostic factor is the mitotic count. Fletcher et al7 defined a
prognostic classification that is widely accepted and used
presently. Pathological factors that can be used to deter-
mine malignancy are the tumor size, mitotic activity, nu-
cleus pleomorphism, cellularity degree, nucleus to
cytoplasm ratio, and mucosal invasion.4 The presence of
the kit protein (CD117), a transmembrane receptor linked
to an intracytoplasmic tyrosine kinase, is the classic finding
in GISTs, and 95% of all cases are CD117 positive. In most
cases, strong positivity is observed for CD117 (w95%) and
CD34 (w70%).9 Therefore, positive results for these pro-
teins in immunohistochemical examination facilitate
establishing the diagnosis.
Most GISTs are > 5 cm in diameter at diagnosis, with a
10-cm diameter being associated with a higher risk of local
or distant metastasis.3 The prognosis of GISTs is dismal
when they present with symptoms or signs such as perfo-
ration or rupture, multifocal location, or metastatic le-
sions. Patients with localized or locally advanced tumors
have a 5-year survival rate of 46%, except for those with
metastatic or multifocal tumors. Such patients have a 5-
year survival rate of 24%, probably because of peritoneal
dissemination.10
Lymph node spread is rare, and formal lymph node
dissection has no proven advantage.9 Our patient was
diagnosed with a high-risk malignant GIST because of the
tumor size and rupture. Because the rupture of a GIST is a
critical prognostic factor that renders it a high-risk tumor,
care must be taken during surgery to prevent complications
such as iatrogenic perforations or ruptures.3
Imatinib mesylate has revolutionized the therapy of
advanced GISTs and is the first effective, worldwide-
approved nonsurgical treatment for inoperable and meta-
static cases.10 GIST response to conventional chemotherapy
is extremely poor (< 10%), whereas radiotherapy is used
only in cases of intraperitoneal hemorrhage, when the
precise location of the tumor is known, or for analgesic
purposes.4 Targeted therapy using the tyrosine kinase in-
hibitor imatinib, a novel adjuvant treatment administered
after surgery, increases survival, suppresses tumor growth,
and has moderate toxicity.3
GISTs originating in the jejunum lead to central necrosis
and spontaneous rupture in the peritoneal cavity; however,
the local excision of the tumor treated with adjuvant
therapy with imatinib mesylate is effective. These treat-
ments remain the main treatment modality for high-risk
GISTs.2 The 5-year survival rate is 35%, which increases to
54% after complete surgical excision.6 Partial resection
must be performed only in cases of large tumors, for
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plications such as compression of other organs, hemor-
rhage, or pain.4 Complete surgical resection is associated
with a 5-year survival rate of 48e65%.5
4. Conclusion
A GIST should be suspected in cases of sudden abdominal
pain in patients with an intra-abdominal mass.3 Sponta-
neous rupture is a rare presentation of GISTs, and preop-
erative diagnosis is difficult because of the absence of
pathognomonic signs or symptoms.2 Patients with GISTs
have limited treatment options. Complete surgical resec-
tion without extensive lymph node sampling remains the
primary treatment option; however, even this option yields
poor outcomes and recurrence.1 We report the case of a
woman with a spontaneously ruptured GIST originating in
the jejunum that presented as acute diffuse peritonitis.
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